
Keywords: Lycopene; Amyloidogenesis; Cognitive impairments; Neuroinflammation; Oxidative stress; MAPKs /NFκB/ Nrf2 signaling pathways; LYC; Lycopene; LPS; Lipopolysaccharide; AD; Alzheimer's disease; PD; Parkinson's disease; CNS; Central nervous system; Aβ; A